Ceftriaxone + Tazobactum in pharma franchise in Karnataka

Name: Fritcet TZ 281.25 Injection (Ceftriaxone 250mg + Tazobactam 31.25mg)
Brand: Fritcet TZ 281.25 Injection
Rating: 4.8 (150 reviews)

Ceftriaxone + Tazobactum in PCD pharma franchise in Shillong

Ceftriaxone + Tazobactum in top pharma company in Ranchi

Ceftriaxone + Tazobactum in pcd pharma supplier in Bhubaneswar

Ceftriaxone + Tazobactum in phama franchise company in India

Ceftriaxone + Tazobactum in phama distributor in Nanded

Home/Products /ceftriaxone-250mg-tazobactum-31-point-25mg-injection

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Ceftriaxone (250mg) + Tazobactam (31.25mg) Injection at Best Price from Pharma Export Companies in India for Bacterial Infections.

Ceftriaxone (250mg) + Tazobactam (31.25mg) Injection at Best Price from Best Pharma Company for Bacterial Infections.

Fritcet TZ 281.25 Injection at Best Price in Antibiotic Franchise for Bacterial Infections.

Fritcet TZ 281.25 Injection

Composition : Ceftriaxone (250mg) + Tazobactum (31.25mg)

Dosage Form : Injection

Packaging Type : Vial + Water

Packaging : 281.25mg

Price : ₹92/-

Contact For Business Query

Fritcet TZ 281.25 Injection combines the potent antibiotic ceftriaxone with tazobactam, designed to enhance its efficacy against a broad spectrum of bacterial infections. Ceftriaxone is a third-generation cephalosporin that targets gram-positive and gram-negative bacteria, making it effective for various infections, including respiratory, urinary tract, and skin infections. Tazobactam, a beta-lactamase inhibitor, safeguards ceftriaxone from degradation by certain bacteria, thereby improving its effectiveness in treating resistant strains.

This injectable formulation is particularly valuable in hospital settings, where it is used to manage serious infections, including those associated with sepsis and surgical procedures. Administered intravenously or intramuscularly, Fritcet TZ 281.25 ensures rapid delivery of the active ingredients, promoting quick therapeutic action.

About the Product

Potential side effects may include allergic reactions, gastrointestinal disturbances, and changes in liver enzyme levels. Monitoring is recommended during therapy.

Fritcet TZ 281.25 Injection is indicated for the treatment of moderate to severe bacterial infections, including pneumonia, skin infections, and intra-abdominal infections.

Consult a healthcare professional before use, especially in patients with a history of allergies to beta-lactam antibiotics. In summary, Fritcet TZ 281.25 Injection stands out as a reliable option for clinicians seeking to combat challenging bacterial infections. Its dual-action formula addresses the increasing concern of antibiotic resistance, providing a robust treatment choice in acute care settings. Always follow healthcare guidance regarding dosing and administration to ensure optimal outcomes and minimize risks associated with therapy.

Store at room temperature, away from light and moisture. Do not freeze.